IP Library Granted Patent US 9,701,993
Granted Patent B2
US 9,701,993 · App. 13/816,911 · Granted Jul 11, 2017

Artificial translation/synthesis system

Inventors: Hiroaki Suga (Tokyo, JP); Hiroshi Murakami (Tokyo, JP); Yuki Goto (Tokyo, JP)
Assignee: THE UNIVERSITY OF TOKYO
C12P21/00C12N15/67C12P21/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,701,993
App. No.
13/816,911
Granted
Jul 11, 2017
Kind
B2
Abstract

A new artificial translation-synthesis system of adding tRNAs binding special amino acids to the in vitro translation system and synthesizing peptides with special amino acids incorporated thereto according to a dual genetic code table and an artificial codon box division.

Claims (28)

1. A method for synthesizing peptides using dual sense codons and artificial division of codon boxes, comprising:

i) combining at least the following in an in vitro translation system:

(a) mRNAs;

(b) initiator tRNA(s) each charged with a (b) artificial amino acid;

(c) elongator tRNA(s) each charged with a (c) natural amino acid, wherein each of the (c) tRNA(s) is independently complementary to first codon(s) of the mRNA of its (c) natural amino acid in the genetic code;

(d) elongator tRNA(s) each charged with a (d) artificial amino acid, wherein at least one of the (d) tRNA(s) is independently complementary to second codon(s) of the mRNA of an (c) natural amino acid in the genetic code;

(e) optionally, initiator tRNA(s) and/or elongator tRNA(s) each charged with a natural or an artificial amino acid,

wherein a codon for each (b) initiator tRNA is the same as a codon for a (c) elongator tRNA or a (d) elongator tRNA; and

ii) synthesizing at least one peptide comprising a (b) artificial amino acid, a (c) natural amino and a (d) artificial amino acid using the mRNAs and tRNA(s) in the in vitro translation system,

wherein a codon for a (b) initiator tRNA of the (b) artificial amino acid is the same as a codon for a (c) elongator tRNA of the (c) natural amino acid or a codon for a (d) elongator tRNA of the (d) artificial amino acid, and

wherein the (b) artificial amino acid and the (d) artificial amino acid in the at least one peptide are different if the codon for the (b) initiator tRNA is the same as the codon for the (d) elongator tRNA.

2. The method according to claim 1 , wherein the (b) initiator tRNA(s) each charged with a (b) artificial amino acid and (d) elongator tRNA(s) each charged with a (d) artificial amino acid are prepared by an in vitro aminoacylation of tRNAs formed by in vitro transcription.

3. The method according to claim 1 , wherein the

(c) natural amino acid is one or more selected from Leu, Val, Ser, Pro, Thr, Ala, Arg, and Gly.

4. The method according to claim 3 , wherein a codon for a (e) elongator tRNA charged with an (e) artificial amino acid may be a termination codon selected from UAG, UAA and UGA.

5. The method according to claim 1 or 2 , wherein the translation system comprises in vitro transcribed tRNAs that are capable of being charged with the natural amino acids by the catalysis of endogenous ARSs.

6. The method according to claim 1 or 2 , wherein the codon assigning the translation initiation is AUG.

7. The method according to claim 1 or 2 , wherein codon(s) for (b) initiator tRNA(s) are selected from AUG, UGG, AUC, ACC, UCG, AAC, GCC, GGC, CCG, CGG, GGG, and AUA.

8. The method according to claim 6 , wherein AUG is a codon for a (d) elongator tRNA charged with an (d) artificial amino acid.

9. The method according to claim 7 , wherein codon(s) for (b) initiator tRNA(s) are selected from AUG, UGG, AUC, ACC, UCG and ACC.

10. A kit for an in vitro translation system that expresses a nonstandard peptide using dual sense codons and artificial division of codon boxes, comprising at least:

(a) a ribosome

(b) initiator tRNA(s) each charged with a (b) artificial amino acid;

(c) elongator tRNA(s) each charged with a (c) natural amino acid, wherein each of the (c) tRNA(s) is independently complementary to first codon(s) of the mRNA of its (c) natural amino acid in the genetic code;

(d) elongator tRNA(s) each charged with a (d) artificial amino acid, wherein at least one of the (d) tRNA(s) is independently complementary to second codon(s) of the mRNA of an (c) natural amino acid in the genetic code,

(e) optionally, initiator tRNA(s) and/or elongator tRNA(s) each charged with a natural or an artificial amino acid,

wherein a codon for each (b) initiator tRNA is the same as a codon for a (c) elongator tRNA or a (d) elongator tRNA.

11. The method according to claim 1 or 2 , wherein a codon for a (b) initiator tRNA can be selected from any triplet sequence.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2013
From: SUGA, HIROAKI; MURAKAMI, HIROSHI; GOTO, YUKI
To: THE UNIVERSITY OF TOKYO
Reel/Frame 029819/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2013
From: SUGA, HIROAKI; MURAKAMI, HIROSHI; GOTO, YUKI
To: THE UNIVERSITY OF TOKYO
Reel/Frame 029831/0135 →
Priority Claims (1)
JP 2010-190315 · Aug 27, 2010 · national
Continuity (1)
Related Publication 20130217599A1 · Aug 22, 2013